Eledon Pharmaceuticals Statistics
Total Valuation
ELDN has a market cap or net worth of $132.26 million. The enterprise value is $39.58 million.
Important Dates
The last earnings date was Friday, November 14, 2025, after market close.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ELDN has 75.15 million shares outstanding. The number of shares has increased by 94.74% in one year.
| Current Share Class | 75.03M |
| Shares Outstanding | 75.15M |
| Shares Change (YoY) | +94.74% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 36.12% |
| Float | 39.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.16 |
| P/TBV Ratio | 2.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.74, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.74 |
| Quick Ratio | 6.59 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -95.49% and return on invested capital (ROIC) is -64.20%.
| Return on Equity (ROE) | -95.49% |
| Return on Assets (ROA) | -44.22% |
| Return on Invested Capital (ROIC) | -64.20% |
| Return on Capital Employed (ROCE) | -74.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.67M |
| Employee Count | 31 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ELDN has paid $431,000 in taxes.
| Income Tax | 431,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.78% in the last 52 weeks. The beta is 0.75, so ELDN's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | -58.78% |
| 50-Day Moving Average | 2.93 |
| 200-Day Moving Average | 3.21 |
| Relative Strength Index (RSI) | 28.91 |
| Average Volume (20 Days) | 3,674,896 |
Short Selling Information
The latest short interest is 4.28 million, so 5.70% of the outstanding shares have been sold short.
| Short Interest | 4.28M |
| Short Previous Month | 3.52M |
| Short % of Shares Out | 5.70% |
| Short % of Float | 10.76% |
| Short Ratio (days to cover) | 2.73 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -86.46M |
| Pretax Income | -79.36M |
| Net Income | -82.67M |
| EBITDA | n/a |
| EBIT | -86.46M |
| Earnings Per Share (EPS) | -$1.10 |
Full Income Statement Balance Sheet
The company has $93.40 million in cash and $722,000 in debt, giving a net cash position of $92.68 million or $1.23 per share.
| Cash & Cash Equivalents | 93.40M |
| Total Debt | 722,000 |
| Net Cash | 92.68M |
| Net Cash Per Share | $1.23 |
| Equity (Book Value) | 91.05M |
| Book Value Per Share | 1.52 |
| Working Capital | 82.01M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -67.24M |
| Capital Expenditures | n/a |
| Free Cash Flow | -67.24M |
| FCF Per Share | -$0.89 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ELDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -94.74% |
| Shareholder Yield | -94.74% |
| Earnings Yield | -62.50% |
| FCF Yield | -50.84% |
Analyst Forecast
The average price target for ELDN is $12.50, which is 610.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.50 |
| Price Target Difference | 610.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -1.58% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 5, 2020. It was a reverse split with a ratio of 1:18.
| Last Split Date | Oct 5, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:18 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |